U.S. Markets open in 39 mins

6 Positions the Vanguard Health Care Fund Continues to Increase

- By Tiziano Frateschi

The Vanguard Health Care Fund (Trades, Portfolio) bought shares of the following stocks in both the fourth quarter of 2018 and first quarter of 2019.


CVS Health Corp. (CVS)

In the fourth quarter, the fund boosted its position by 160.8% and added 7.15% in the first quarter.

3b9d9910-6d88-11e9-a135-a510f33a5a1c.png

With a market cap of $73.70 billion, the retail pharmacy chain's revenue of $210.53 billion has grown 13.30% over the last five years.

Barrow, Hanley, Mewhinney & Strauss is the largest guru shareholder of the company with 1.48% of outstanding shares, followed by Dodge & Cox with 1.24% and Vanguard with 0.97%

Teva Pharmaceutical Industries Ltd. (TEVA)

Vanguard added 9.34% to its holding in the fourth quarter and another 65.14% in the first quarter.

575460d0-6d88-11e9-8386-e3d401c3de99.png

The pharmaceutical company has a market cap of $14 billion. Its revenue of $44.38 billion has declined 4.20% over the last five years.

The company's largest guru shareholder is Warren Buffett (Trades, Portfolio) with 3.97% of outstanding shares, followed by Vanguard with 3.53%, David Abrams (Trades, Portfolio) with 1.70% and Jim Simons (Trades, Portfolio)' Renaissance Technologies with 0.23%.

Nektar Therapeutics Inc. (NKTR)

The fund increased its holding by 37.9% in the fourth quarter and by 23.12% in the first quarter.

7819ff50-6d88-11e9-9fc1-5f842a5a0004.png

The biopharmaceutical company has a market cap of $5.60 billion. Its revenue of $1.19 billion has climbed 24.70% over the last five years.

PRIMECAP Management (Trades, Portfolio) is the largest guru shareholder of the company with 11.14% of outstanding shares, followed by Simons' firm with 0.23%, Pioneer Investments (Trades, Portfolio) with 0.17% and Joel Greenblatt (Trades, Portfolio) with 0.10%.

Elanco Animal Health Inc. (ELAN)

In the fourth quarter, the Health Care Fund added 16.45% to the holding and boosted it another 895.29% in the first quarter.

925b2f90-6d88-11e9-81ea-f1c99f4c5bba.png

The company, which operates in the Drug Manufacturers - Specialty and Generic industry, has a market cap of $11.47 billion. Its revenue of $3.06 billion has not changed over the last five years.

Another notable guru shareholder of the company is Pioneer Investments with 2.86% of outstanding shares, followed by PRIMECAP Management with 1.36%, David Carlson (Trades, Portfolio) with 0.15% and Steven Cohen (Trades, Portfolio) with 0.09%.

Centene Corp. (CNC)

Vanguard added 35.68% to its position in the fourth quarter and boosted it 193.36% in the first quarter.

a9d516a0-6d88-11e9-978c-ab52ba47a744.png

The health care plans provider has a market cap of $21.34 billion. Its revenue of $65.36 billion has grown 25.90% over the last five years.

Another notable guru shareholder is Lee Ainslie (Trades, Portfolio) with 0.87% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 0.19% and Jana Partners (Trades, Portfolio) with 0.19%.

Ironwood Pharmaceuticals Inc. (IRWD)

The fund added 1.75% to the position in the fourth quarter and increased it 111.67% in the first quarter.

be7d8460-6d88-11e9-9295-459d83122a20.png

With a market cap of $1.60 billion, the company manufactures specialty and generic drugs. Its revenue of $346.64 million has grown 60.70% over the last five years.

Another notable guru shareholder is Ken Fisher (Trades, Portfolio) with 0.12% of outstanding shares, followed by Greenblatt with 0.01%.

Disclosure: I do not own any stocks mentioned in this article.

Read more here:

  • Wallace Weitz Exits Allergan, Trims Liberty Broadband Position
  • 8 Stocks Richard Pzena Continues to Buy
  • Chuck Akre Adds to American Tower, CarMax



N ot a Premium Member of GuruFocus? Sign up for a free 7-day trial here .

This article first appeared on GuruFocus.